Tag: Gilead Sciences

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Gilead Sciences

Examining Remdesivir in Elderly Patients Hospitalized for COVID-19 | ASHP Midyear

Added to Collection on: 2024-12-11 08:44:25

Tags for this article:

COVID-19 drug development
Nitriles
Antiviral drugs
Orphan drugs
Remdesivir
Gilead Sciences
COVID-19
Baricitinib
COVID-19 drug repurposing research
NEW ORLEANS

Click the tags to see associated articles and topics

View Article Details
Despite Remdesivir's Known History of Lethality, the Defense Department Continues to ... - WCBM

Added to Collection on: 2024-12-17 16:58:11

Tags for this article:

Nitriles
COVID-19 drug development
Orphan drugs
Antiviral drugs
Remdesivir
Gilead Sciences
Treatment and management of COVID-19
CENCORA
COVID-19

Click the tags to see associated articles and topics

View Article Details
Top medical advances of 2024: Game-changing medicines and procedures - STAT News

Added to Collection on: 2024-12-30 16:23:59

Tags for this article:

Gilead Sciences
Antiretroviral drugs
Orphan drugs
Pre-exposure prophylaxis for HIV prevention
Rare diseases
Lenacapavir
Semaglutide
Anti-obesity medication
GLP-1 receptor agonist
Emtricitabine/tenofovir
Gene therapy
Medication

Click the tags to see associated articles and topics

View Article Details
Long-acting HIV prevention meds: 10 Breakthrough Technologies 2025

Added to Collection on: 2025-01-04 13:01:41

Tags for this article:

Specialty drugs
Antiretroviral drugs
Gilead Sciences
Amides
Chloroarenes
Lenacapavir
ViiV Healthcare
gsk plc
Medication
Pre-exposure prophylaxis for HIV prevention

Click the tags to see associated articles and topics

View Article Details
Mel Gibson claims Covid drug paralyzed him and killed his friend - Daily Mail

Added to Collection on: 2025-01-10 17:56:21

Tags for this article:

COVID-19 drug development
Nitriles
Antiviral drugs
Nucleotides
Remdesivir
Gilead Sciences
Joe Rogan
COVID-19
Mel Gibson
Donald Trump

Click the tags to see associated articles and topics

View Article Details
Advancing LBCL Treatment Through MRD Monitoring and Allogeneic CAR T-Cell Therapy

Added to Collection on: 2025-01-22 14:20:47

Tags for this article:

Lymphoma
Non-Hodgkin lymphoma
Pediatric cancers
Gilead Sciences
Anatomical pathology
Kite Pharma
Diffuse large B-cell lymphoma
Acute lymphoblastic leukemia
CHOP
Axicabtagene ciloleucel
CAR T cell
Rituximab
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Gilead Treatment for PBC Granted EC Conditional Marketing Authorization - PharmTech

Added to Collection on: 2025-02-21 21:48:55

Tags for this article:

Orphan drugs
Hepatology
Bile acids
Cholanes
Autoimmune diseases
Primary biliary cholangitis
Cholestasis
Ursodeoxycholic acid
Seladelpar
Gilead Sciences
Obeticholic acid
Setanaxib

Click the tags to see associated articles and topics

View Article Details
Biotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & More - March 13, 2025

Added to Collection on: 2025-03-13 13:45:59

Tags for this article:

Fluoroarenes
Gilead Sciences
Chloroarenes
Cyclopropanes
Lenacapavir
Sulfonamides
Icotrokinra
Bictegravir/emtricitabine/tenofovir alafenamide
Ulcerative colitis
Bristol-Myers Squibb

Click the tags to see associated articles and topics

View Article Details
Phase I Trial Supports Development of Once-Yearly Lenacapavir as Long-Acting HIV PrEP Option

Added to Collection on: 2025-03-13 17:35:32

Tags for this article:

Prevention of HIV/AIDS
Gilead Sciences
Hepatotoxins
Fluoroarenes
Antiretroviral drugs
Lenacapavir
Pre-exposure prophylaxis for HIV prevention
Management of HIV/AIDS
HIV/AIDS
Tenofovir disoproxil
HIV
HIV Prevention Trials Network

Click the tags to see associated articles and topics

View Article Details
Overcoming CAR T Manufacturing Failure in LBCL

Added to Collection on: 2025-03-21 14:30:34

Tags for this article:

Gilead Sciences
Axicabtagene ciloleucel
CAR T-cell therapy
CAR T cell
Lymphoma
AXI
Kite Pharma
United Kingdom

Click the tags to see associated articles and topics

View Article Details